|
SYNARC to Demo StudyDirect™ at ASCO 2011 Annual MeetingSan Francisco – May 31, 2011 – SYNARC, the world’s leading provider of medical imaging services for the pharmaceutical, biotechnology, and medical device industries, announced today that the company will be conducting demonstrations of its StudyDirect™ its image management and analysis platform during the 2011 ASCO annual meeting in Chicago on May 31st. StudyDirect is a proprietary, web-based, 21 CFR Part 11-compliant system. Key features include an image browser, electronic data capture, and reporting capabilities consistent with industry-standardization efforts. StudyDirect also offers as automated query generation and workflow management for improved operational efficiency and quality in managing study data. SYNARC now uses StudyDirect in more than 100 clinical trials across the globe in the Musculoskeletal, Neurology, and Oncology therapeutic areas. Demonstrations will be given daily at the SYNARC booth #13116, by Dr. Souhil Zaim, SYNARC’s Vice President of Radiology Services. About CCBR-SYNARC CCBR-SYNARC’s medical image analysis, biochemical marker, and clinical research center services enable life-science industry clients to execute clinical trials accurately while decreasing the time, uncertainty, and cost of product development. CCBR-SYNARC has partnered with industry leaders to bring numerous leading compounds to market across a broad spectrum of therapeutic areas. Our services integrate critical aspects of clinical trial design and execution, from protocol design and subject recruitment to regulatory liaison on behalf of our clients. Our expert radiologists and scientists are innovators in all aspects of medical image analysis and biochemical markers in drug development, and have pioneered many methods used in today’s clinical trials. # # #
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| © Copyright 2012 SYNARC Inc. Legal Statement |